BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 27870469)

  • 1. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-Based Circulating MicroRNAs are Potential Diagnostic Biomarkers for Leukemia: Result from a Meta-Analysis.
    Xu LH; Guo Y; Zhang XL; Chen JJ; Hu SY
    Cell Physiol Biochem; 2016; 38(3):939-49. PubMed ID: 26938054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive power of circulating miRNAs in detecting colorectal cancer.
    Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
    Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
    Xu SL; Tian YY; Zhou Y; Liu LQ
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Chen L; Cui Z; Liu Y; Bai Y; Lan F
    Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
    Wu K; Li L; Li S
    Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.
    Zi Y; Yin Z; Xiao W; Liu X; Gao Z; Jiao L; Deng L
    Mol Neurobiol; 2015 Dec; 52(3):1494-1503. PubMed ID: 25367880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
    Ma C; Nguyen HPT; Luwor RB; Stylli SS; Gogos A; Paradiso L; Kaye AH; Morokoff AP
    PLoS One; 2018; 13(2):e0189452. PubMed ID: 29444091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of circulating microRNAs for nasopharyngeal cancer: a systematic review and meta-analysis.
    Wang Z; Chen W; Zhang Y; Xu L; Wang Q
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C173-8. PubMed ID: 25450278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs used as novel biomarkers for detecting cancer metastasis.
    Han C; Yu H; Zhang L; Li X; Feng Y; Xin H
    Tumour Biol; 2015 Mar; 36(3):1755-62. PubMed ID: 25366141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of circulating microRNAs for gastric cancer in Asian populations: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):11995-2004. PubMed ID: 25159040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: a meta-analysis.
    Zhang M; Zhao LJ; Liang WQ; Mao ZP
    Genet Mol Res; 2015 Dec; 14(4):16562-76. PubMed ID: 26681002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis.
    Wang X; Ning Y; Yang L; Liu H; Wu C; Wang S; Guo X
    Clin Exp Med; 2017 May; 17(2):175-183. PubMed ID: 27106278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating MicroRNAs as Potential Diagnostic Biomarkers for Diabetic Retinopathy: A Meta-Analysis.
    Ma L; Wen Y; Li Z; Wu N; Wang Q
    Front Endocrinol (Lausanne); 2022; 13():929924. PubMed ID: 35898469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of miRNAs as potential biomarkers for systemic lupus erythematosus: a meta-analysis.
    Dai ZW; Wang H; Xu WJ; Wang ZH; Xu SQ; Wang B; Ye DQ
    Clin Rheumatol; 2018 Nov; 37(11):2999-3007. PubMed ID: 29980876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of circulating microRNAs as diagnostic biomarkers for ovarian cancer:A pooled analysis of individual studies.
    Zhou Q; Zuo MZ; He Z; Li HR; Li W
    Int J Biol Markers; 2018 Apr; ():1724600818766500. PubMed ID: 29683066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations.
    Xiang Y; Zhang L; Xiang P; Zhang J
    Front Oncol; 2021; 11():698197. PubMed ID: 34307166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.